Cellebrite DI Ltd. (CLBT) Stock Overview
Explore Cellebrite DI Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Cellebrite DI Ltd. (CLBT)
Key Financials
Key Financials
Market Cap
3.6B
P/E Ratio
49.71
EPS (TTM)
$0.28
ROE
0.16%
CLBT Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Cellebrite DI Ltd. (CLBT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 54.36, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.75.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 49.71 and a market capitalization of 3.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.